Filing Flows › Core Scientific, Inc./tx (CORZ) › Stock forecast & fair value
Core Scientific, Inc./tx (CORZ) stock forecast and fair value
Core Scientific, Inc./tx (CORZ) trades at $15.41. 21 analysts' median price target is $30.00 (+95%), from $16.00 to $38.00. Across 11 valuation methods the middle fair value is −$4.26 (-128%).
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| EV/Sales vs peers, weighted | −$1.35 | $1.07 | $5.79 | -93% |
| Analysts' price targets | $16.00 | $28.48 | $38.00 | +85% |
| Path-to-margin DCF | −$38.36 | −$37.26 | −$36.17 | -342% |
| Path-to-margin DCF, dilution-adjusted | −$11.19 | −$10.95 | −$10.70 | -171% |
| Exit-multiple (venture) method | $0.28 | $0.50 | $1.46 | -97% |
| EV/Sales vs Rule of 40 (all-company fit) | −$7.35 | −$6.62 | −$4.62 | -143% |
| Survival-weighted value | −$6.82 | −$6.67 | −$6.52 | -143% |
| Stage-weighted value (pre-profit / high growth) | −$6.51 | −$6.21 | −$5.47 | -140% |
| Combined forecast (3 months) | $12.62 | $16.02 | $19.85 | +4% |
| Schwartz–Moon simulation (cash can run out) | $0.00 | $0.00 | $0.00 | — |
Core Scientific, Inc./tx's latest quarter
Core Scientific, Inc./tx, Q3 2026: revenue $233M (+187% year over year), operating margin 31.1%, net earnings $1.2B, operating cash flow $65.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for CORZ stock?
The median of 21 analysts' 12-month targets is $30.00, +95% from $15.41; the range is $16.00 to $38.00. The average rating is strong buy.
What is Core Scientific, Inc./tx's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between −$37.26 and $28.48, with a middle value of −$4.26 against a price of $15.41. Each method's assumptions are on the page.
Does Core Scientific, Inc./tx usually beat earnings estimates?
It beat the consensus EPS estimate in 40% of the quarters on record.
Is CORZ stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.